WO2008065144A3 - Préparations galéniques de composés organiques - Google Patents

Préparations galéniques de composés organiques Download PDF

Info

Publication number
WO2008065144A3
WO2008065144A3 PCT/EP2007/062960 EP2007062960W WO2008065144A3 WO 2008065144 A3 WO2008065144 A3 WO 2008065144A3 EP 2007062960 W EP2007062960 W EP 2007062960W WO 2008065144 A3 WO2008065144 A3 WO 2008065144A3
Authority
WO
WIPO (PCT)
Prior art keywords
organic compounds
galenic formulations
dosage form
present
amount
Prior art date
Application number
PCT/EP2007/062960
Other languages
English (en)
Other versions
WO2008065144A2 (fr
Inventor
Begona Carreno-Gomez
Original Assignee
Novartis Ag
Begona Carreno-Gomez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Begona Carreno-Gomez filed Critical Novartis Ag
Publication of WO2008065144A2 publication Critical patent/WO2008065144A2/fr
Publication of WO2008065144A3 publication Critical patent/WO2008065144A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne une forme posologique pour administration transmuqueuse comprenant une quantité thérapeutiquement efficace de PTH ou d'un sel pharmaceutiquement acceptable de ce dernier, ainsi qu'un excipient pour l'administration transmuqueuse, l'ingrédient actif étant présent en proportion comprise entre 0,001 et 80% en poids sur la base du poids total de la forme posologique.
PCT/EP2007/062960 2006-11-29 2007-11-28 Préparations galéniques de composés organiques WO2008065144A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06125019 2006-11-29
EP06125019.7 2006-11-29

Publications (2)

Publication Number Publication Date
WO2008065144A2 WO2008065144A2 (fr) 2008-06-05
WO2008065144A3 true WO2008065144A3 (fr) 2009-03-19

Family

ID=37872188

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/062960 WO2008065144A2 (fr) 2006-11-29 2007-11-28 Préparations galéniques de composés organiques

Country Status (1)

Country Link
WO (1) WO2008065144A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009125432A2 (fr) * 2008-04-11 2009-10-15 Lupin Limited Systèmes d'administration de médicament expansible alimentés par gaz
DE102011088909A1 (de) 2011-08-12 2013-02-14 Labtec Gmbh Verfahren zur Herstellung und Kontrolle von oralen Wirkstoff-Filmen
MY195591A (en) 2017-01-11 2023-02-02 Ferring Bv A Fast Disintegrating Pharmaceutical Composition

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578567A (en) * 1990-09-20 1996-11-26 Sandoz Ltd. Nasal pharmaceutical composition
US20050276843A1 (en) * 2004-05-10 2005-12-15 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of parathyroid hormone
WO2006076692A1 (fr) * 2005-01-12 2006-07-20 Emisphere Technologies, Inc. Compositions pour l'administration orale de l'hormone parathyroide
US20060189533A1 (en) * 2004-05-10 2006-08-24 Nastech Pharmaceutical Company Inc. Stable pharmaceutical dosage forms of teriparatide

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578567A (en) * 1990-09-20 1996-11-26 Sandoz Ltd. Nasal pharmaceutical composition
US20050276843A1 (en) * 2004-05-10 2005-12-15 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of parathyroid hormone
US20060189533A1 (en) * 2004-05-10 2006-08-24 Nastech Pharmaceutical Company Inc. Stable pharmaceutical dosage forms of teriparatide
WO2006076692A1 (fr) * 2005-01-12 2006-07-20 Emisphere Technologies, Inc. Compositions pour l'administration orale de l'hormone parathyroide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MORLEY PAUL: "DELIVERY OF PARATHYROID HORMONE FOR THE TREATMENT OF OSTEOPOROSIS", EXPERT OPINION ON DRUG DELIVERY, ASHLEY PUBLICATIONS, XX, vol. 2, no. 6, November 2005 (2005-11-01), pages 993 - 1002, XP008076969, ISSN: 1742-5247 *

Also Published As

Publication number Publication date
WO2008065144A2 (fr) 2008-06-05

Similar Documents

Publication Publication Date Title
WO2008023016A3 (fr) Formulations galéniques de composés organiques
MY148773A (en) Galenic formulations of organic compounds
WO2007009806A3 (fr) Formulations posologiques solides de medicaments narcotiques presentant une adsorption buccale amelioree
WO2006058249A3 (fr) Procedes et compositions destines a decourager l'abus de produits pharmaceutiques administres oralement
WO2006133941A3 (fr) Ingredient pharmaceutique actif a base de cannabinoides pour formes posologiques ameliorees
WO2010136474A3 (fr) Dérivés aminobutyriques substitués en tant qu'inhibiteurs de néprilysine
EP1834637A4 (fr) Preparation prophylactique/therapeutique contre une maladie due aux radicaux libres
WO2007106550A3 (fr) Procédés et compositions de dissuasion d'abus de produits pharmaceutiques à administration orale
NZ600231A (en) Pharmaceutical compositions comprising sigma receptor ligands
WO2006050002A3 (fr) Compositions destinees a l'administration controlee de composes pharmaceutiquement actifs
NZ587202A (en) Methods for measuring a patient response upon administration of a drug and compositions thereof
WO2008144269A3 (fr) Methodes d'utilisation d'antagonistes de vasopressine avec des agents chimiotherapeutiques a base d'anthracycline visant a reduire la cardiotoxicite et/ou ameliorer la survie
WO2006008173A3 (fr) Formulations pharmaceutiques
UA96622C2 (ru) Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования
WO2006115770A3 (fr) Preparations pharmaceutiques d'olazanpine en comprimes a desintegration orale
WO2007145863A3 (fr) Formulation à libération prolongée de naltréxone
WO2008062475A3 (fr) Compositions pharmaceutiques d'ursodiol
WO2010003472A3 (fr) Composition à sucer pour le traitement d'affections inflammatoires de la cavité buccale et du pharynx
WO2007011958A3 (fr) Formes posologiques intra-buccales de glucagon
WO2008065144A3 (fr) Préparations galéniques de composés organiques
TN2010000120A1 (en) Galenical formulations of organic compounds
WO2007120930A3 (fr) Compositions pharmaceutiques stables de derives de l'acide 2-aza-bicyclo[3.3.0]-octane-3-carboxylique
MA32722B1 (fr) Formulation galénique renfermant de l'aliskirène et procédé associé de préparation par granulation par fusion-extrusion
WO2007047881A3 (fr) Methode de traitement de la douleur
WO2003070153A3 (fr) Compositions pharmaceutiques stabilisees d'halofuginone et d'autres derives de quinazolinone

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07847477

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07847477

Country of ref document: EP

Kind code of ref document: A2